Development and external validation of a novel nomogram to predict prostate cancer in biopsy‐naïve patients with PSA <10 ng/ml and PI‐RADS v2.1 = 3 lesions

Objective To develop and externally validate a novel nomogram in biopsy‐naïve patients with prostate‐specific antigen (PSA)

Saved in:
Bibliographic Details
Published in:Cancer medicine (Malden, MA) MA), 2023-02, Vol.12 (3), p.2560-2571
Main Authors: Hu, Can, Sun, Jiale, Xu, Zhenyu, Zhang, Zhiyu, Zhou, Qi, Xu, Jiangnan, Chen, Hao, Wang, Chao, Ouyang, Jun
Format: Article
Language:English
Subjects:
Antigens
Biopsy
Calibration
csPCa
Decision making
Diffusion coefficient
equivocal lesions
Humans
Lesions
Magnetic Resonance Imaging
Male
nomogram
Nomograms
Patients
PI‐RADS v2.1
Prostate cancer
Prostate-Specific Antigen
Prostatic Neoplasms - pathology
Regression analysis
Retrospective Studies
Risk factors
Software
Urology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To develop and externally validate a novel nomogram in biopsy‐naïve patients with prostate‐specific antigen (PSA)
ISSN:2045-7634
2045-7634
DOI:10.1002/cam4.5100